nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP3A4—type 2 diabetes mellitus	0.184	1	CbGaD
Temsirolimus—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0369	0.078	CbGbCtD
Temsirolimus—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0369	0.078	CbGbCtD
Temsirolimus—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0369	0.0779	CbGbCtD
Temsirolimus—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0329	0.0695	CbGbCtD
Temsirolimus—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0277	0.0585	CbGbCtD
Temsirolimus—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0238	0.0502	CbGbCtD
Temsirolimus—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0224	0.0473	CbGbCtD
Temsirolimus—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0221	0.0467	CbGbCtD
Temsirolimus—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0207	0.0437	CbGbCtD
Temsirolimus—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0197	0.0416	CbGbCtD
Temsirolimus—CYP3A4—Glipizide—type 2 diabetes mellitus	0.018	0.0381	CbGbCtD
Temsirolimus—CYP3A5—Losartan—type 2 diabetes mellitus	0.0171	0.0361	CbGbCtD
Temsirolimus—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.017	0.0359	CbGbCtD
Temsirolimus—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0163	0.0345	CbGbCtD
Temsirolimus—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0163	0.0344	CbGbCtD
Temsirolimus—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0157	0.0333	CbGbCtD
Temsirolimus—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0142	0.0301	CbGbCtD
Temsirolimus—ABCB1—Glyburide—type 2 diabetes mellitus	0.0122	0.0257	CbGbCtD
Temsirolimus—ABCB1—Losartan—type 2 diabetes mellitus	0.0111	0.0235	CbGbCtD
Temsirolimus—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0108	0.0228	CbGbCtD
Temsirolimus—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0103	0.0219	CbGbCtD
Temsirolimus—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0103	0.0219	CbGbCtD
Temsirolimus—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00978	0.0207	CbGbCtD
Temsirolimus—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00729	0.0154	CbGbCtD
Temsirolimus—CYP3A4—Losartan—type 2 diabetes mellitus	0.00666	0.0141	CbGbCtD
Temsirolimus—MTOR—leg—type 2 diabetes mellitus	0.00629	0.174	CbGeAlD
Temsirolimus—MTOR—hindlimb—type 2 diabetes mellitus	0.00562	0.155	CbGeAlD
Temsirolimus—MTOR—retina—type 2 diabetes mellitus	0.00141	0.0391	CbGeAlD
Temsirolimus—FKBP1A—retina—type 2 diabetes mellitus	0.00127	0.0351	CbGeAlD
Temsirolimus—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.00126	0.0348	CbGeAlD
Temsirolimus—MTOR—cardiovascular system—type 2 diabetes mellitus	0.0012	0.033	CbGeAlD
Temsirolimus—MTOR—kidney—type 2 diabetes mellitus	0.00117	0.0323	CbGeAlD
Temsirolimus—MTOR—pancreas—type 2 diabetes mellitus	0.00116	0.0321	CbGeAlD
Temsirolimus—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.00108	0.0298	CbGeAlD
Temsirolimus—FKBP1A—cardiovascular system—type 2 diabetes mellitus	0.00108	0.0297	CbGeAlD
Temsirolimus—MTOR—adipose tissue—type 2 diabetes mellitus	0.00106	0.0291	CbGeAlD
Temsirolimus—FKBP1A—kidney—type 2 diabetes mellitus	0.00105	0.0291	CbGeAlD
Temsirolimus—FKBP1A—pancreas—type 2 diabetes mellitus	0.00105	0.0289	CbGeAlD
Temsirolimus—FKBP1A—cortex of kidney—type 2 diabetes mellitus	0.00103	0.0283	CbGeAlD
Temsirolimus—FKBP1A—adipose tissue—type 2 diabetes mellitus	0.000949	0.0262	CbGeAlD
Temsirolimus—CYP3A7—liver—type 2 diabetes mellitus	0.000824	0.0227	CbGeAlD
Temsirolimus—MTOR—liver—type 2 diabetes mellitus	0.00074	0.0204	CbGeAlD
Temsirolimus—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.0007	0.0193	CbGeAlD
Temsirolimus—FKBP1A—liver—type 2 diabetes mellitus	0.000666	0.0184	CbGeAlD
Temsirolimus—Everolimus—CYP3A4—type 2 diabetes mellitus	0.000661	0.27	CrCbGaD
Temsirolimus—Pimecrolimus—CYP3A4—type 2 diabetes mellitus	0.000661	0.27	CrCbGaD
Temsirolimus—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000648	0.0179	CbGeAlD
Temsirolimus—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000522	0.0144	CbGeAlD
Temsirolimus—CYP3A5—kidney—type 2 diabetes mellitus	0.000459	0.0127	CbGeAlD
Temsirolimus—CYP3A5—pancreas—type 2 diabetes mellitus	0.000456	0.0126	CbGeAlD
Temsirolimus—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000447	0.0123	CbGeAlD
Temsirolimus—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000413	0.0114	CbGeAlD
Temsirolimus—Tacrolimus—CYP3A4—type 2 diabetes mellitus	0.000393	0.16	CrCbGaD
Temsirolimus—Sirolimus—CYP3A4—type 2 diabetes mellitus	0.000393	0.16	CrCbGaD
Temsirolimus—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000344	0.00951	CbGeAlD
Temsirolimus—CYP3A4—kidney—type 2 diabetes mellitus	0.000344	0.0095	CbGeAlD
Temsirolimus—Tacrolimus—ALB—type 2 diabetes mellitus	0.000343	0.14	CrCbGaD
Temsirolimus—CYP2D6—kidney—type 2 diabetes mellitus	0.000339	0.00935	CbGeAlD
Temsirolimus—ABCB1—retina—type 2 diabetes mellitus	0.000294	0.00813	CbGeAlD
Temsirolimus—CYP3A5—liver—type 2 diabetes mellitus	0.00029	0.008	CbGeAlD
Temsirolimus—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000277	0.00765	CbGeAlD
Temsirolimus—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000249	0.00688	CbGeAlD
Temsirolimus—ABCB1—kidney—type 2 diabetes mellitus	0.000244	0.00673	CbGeAlD
Temsirolimus—ABCB1—pancreas—type 2 diabetes mellitus	0.000242	0.00668	CbGeAlD
Temsirolimus—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000237	0.00655	CbGeAlD
Temsirolimus—ABCB1—adipose tissue—type 2 diabetes mellitus	0.00022	0.00606	CbGeAlD
Temsirolimus—CYP3A4—liver—type 2 diabetes mellitus	0.000218	0.00601	CbGeAlD
Temsirolimus—CYP2D6—liver—type 2 diabetes mellitus	0.000214	0.00591	CbGeAlD
Temsirolimus—ABCB1—liver—type 2 diabetes mellitus	0.000154	0.00425	CbGeAlD
Temsirolimus—Erythema—Losartan—type 2 diabetes mellitus	0.000124	0.00065	CcSEcCtD
Temsirolimus—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000123	0.000648	CcSEcCtD
Temsirolimus—Oedema—Orlistat—type 2 diabetes mellitus	0.000123	0.000648	CcSEcCtD
Temsirolimus—Headache—Glipizide—type 2 diabetes mellitus	0.000123	0.000647	CcSEcCtD
Temsirolimus—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000123	0.000645	CcSEcCtD
Temsirolimus—Infection—Orlistat—type 2 diabetes mellitus	0.000122	0.000644	CcSEcCtD
Temsirolimus—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000122	0.000643	CcSEcCtD
Temsirolimus—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000122	0.000642	CcSEcCtD
Temsirolimus—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000121	0.000638	CcSEcCtD
Temsirolimus—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000121	0.000637	CcSEcCtD
Temsirolimus—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000121	0.000637	CcSEcCtD
Temsirolimus—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000121	0.000636	CcSEcCtD
Temsirolimus—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000121	0.000636	CcSEcCtD
Temsirolimus—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000121	0.000635	CcSEcCtD
Temsirolimus—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000121	0.000635	CcSEcCtD
Temsirolimus—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000121	0.000634	CcSEcCtD
Temsirolimus—Hypertension—Metformin—type 2 diabetes mellitus	0.00012	0.000631	CcSEcCtD
Temsirolimus—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00012	0.000631	CcSEcCtD
Temsirolimus—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.00012	0.00063	CcSEcCtD
Temsirolimus—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00012	0.000629	CcSEcCtD
Temsirolimus—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.000629	CcSEcCtD
Temsirolimus—Back pain—Losartan—type 2 diabetes mellitus	0.00012	0.000628	CcSEcCtD
Temsirolimus—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00012	0.000628	CcSEcCtD
Temsirolimus—Anorexia—Valsartan—type 2 diabetes mellitus	0.000119	0.000625	CcSEcCtD
Temsirolimus—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000119	0.000624	CcSEcCtD
Temsirolimus—Myalgia—Metformin—type 2 diabetes mellitus	0.000119	0.000623	CcSEcCtD
Temsirolimus—Chest pain—Metformin—type 2 diabetes mellitus	0.000119	0.000623	CcSEcCtD
Temsirolimus—Headache—Pioglitazone—type 2 diabetes mellitus	0.000118	0.00062	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000118	0.000618	CcSEcCtD
Temsirolimus—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000118	0.000618	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000117	0.000616	CcSEcCtD
Temsirolimus—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000117	0.000615	CcSEcCtD
Temsirolimus—Nausea—Glipizide—type 2 diabetes mellitus	0.000117	0.000613	CcSEcCtD
Temsirolimus—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000117	0.000613	CcSEcCtD
Temsirolimus—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000116	0.000611	CcSEcCtD
Temsirolimus—Pain—Gliclazide—type 2 diabetes mellitus	0.000116	0.00061	CcSEcCtD
Temsirolimus—Constipation—Gliclazide—type 2 diabetes mellitus	0.000116	0.00061	CcSEcCtD
Temsirolimus—Rash—Glimepiride—type 2 diabetes mellitus	0.000116	0.000607	CcSEcCtD
Temsirolimus—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000116	0.000607	CcSEcCtD
Temsirolimus—Rash—Sitagliptin—type 2 diabetes mellitus	0.000115	0.000606	CcSEcCtD
Temsirolimus—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000115	0.000605	CcSEcCtD
Temsirolimus—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000115	0.000605	CcSEcCtD
Temsirolimus—Headache—Glimepiride—type 2 diabetes mellitus	0.000115	0.000604	CcSEcCtD
Temsirolimus—Cough—Irbesartan—type 2 diabetes mellitus	0.000115	0.000602	CcSEcCtD
Temsirolimus—Headache—Sitagliptin—type 2 diabetes mellitus	0.000115	0.000602	CcSEcCtD
Temsirolimus—Anaemia—Losartan—type 2 diabetes mellitus	0.000114	0.0006	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000114	0.000597	CcSEcCtD
Temsirolimus—Oedema—Metformin—type 2 diabetes mellitus	0.000114	0.000597	CcSEcCtD
Temsirolimus—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000113	0.000596	CcSEcCtD
Temsirolimus—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000113	0.000595	CcSEcCtD
Temsirolimus—Angioedema—Losartan—type 2 diabetes mellitus	0.000113	0.000594	CcSEcCtD
Temsirolimus—Infection—Metformin—type 2 diabetes mellitus	0.000113	0.000593	CcSEcCtD
Temsirolimus—Insomnia—Valsartan—type 2 diabetes mellitus	0.000113	0.000593	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000112	0.00059	CcSEcCtD
Temsirolimus—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000112	0.000588	CcSEcCtD
Temsirolimus—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000112	0.000588	CcSEcCtD
Temsirolimus—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000112	0.000588	CcSEcCtD
Temsirolimus—Insomnia—Orlistat—type 2 diabetes mellitus	0.000112	0.000586	CcSEcCtD
Temsirolimus—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000111	0.000586	CcSEcCtD
Temsirolimus—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000111	0.000585	CcSEcCtD
Temsirolimus—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000111	0.000585	CcSEcCtD
Temsirolimus—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000111	0.000584	CcSEcCtD
Temsirolimus—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000111	0.000584	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000111	0.000584	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000111	0.000583	CcSEcCtD
Temsirolimus—Somnolence—Valsartan—type 2 diabetes mellitus	0.000111	0.000583	CcSEcCtD
Temsirolimus—Leukopenia—Losartan—type 2 diabetes mellitus	0.000111	0.000581	CcSEcCtD
Temsirolimus—Skin disorder—Metformin—type 2 diabetes mellitus	0.00011	0.00058	CcSEcCtD
Temsirolimus—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00011	0.000578	CcSEcCtD
Temsirolimus—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.00011	0.000577	CcSEcCtD
Temsirolimus—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000109	0.000575	CcSEcCtD
Temsirolimus—Nausea—Glimepiride—type 2 diabetes mellitus	0.000109	0.000572	CcSEcCtD
Temsirolimus—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000109	0.00057	CcSEcCtD
Temsirolimus—Asthenia—Glyburide—type 2 diabetes mellitus	0.000109	0.00057	CcSEcCtD
Temsirolimus—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000108	0.00057	CcSEcCtD
Temsirolimus—Anorexia—Metformin—type 2 diabetes mellitus	0.000108	0.000569	CcSEcCtD
Temsirolimus—Cough—Losartan—type 2 diabetes mellitus	0.000108	0.000567	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000108	0.000566	CcSEcCtD
Temsirolimus—Fatigue—Valsartan—type 2 diabetes mellitus	0.000108	0.000565	CcSEcCtD
Temsirolimus—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000107	0.000564	CcSEcCtD
Temsirolimus—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000107	0.000564	CcSEcCtD
Temsirolimus—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000107	0.000563	CcSEcCtD
Temsirolimus—Oedema—Irbesartan—type 2 diabetes mellitus	0.000107	0.000563	CcSEcCtD
Temsirolimus—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000107	0.000563	CcSEcCtD
Temsirolimus—Pruritus—Glyburide—type 2 diabetes mellitus	0.000107	0.000562	CcSEcCtD
Temsirolimus—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000107	0.000561	CcSEcCtD
Temsirolimus—Constipation—Valsartan—type 2 diabetes mellitus	0.000107	0.000561	CcSEcCtD
Temsirolimus—Infection—Irbesartan—type 2 diabetes mellitus	0.000107	0.00056	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000106	0.000559	CcSEcCtD
Temsirolimus—Fatigue—Orlistat—type 2 diabetes mellitus	0.000106	0.000558	CcSEcCtD
Temsirolimus—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000106	0.000557	CcSEcCtD
Temsirolimus—Erythema—Ramipril—type 2 diabetes mellitus	0.000106	0.000557	CcSEcCtD
Temsirolimus—Pain—Orlistat—type 2 diabetes mellitus	0.000105	0.000554	CcSEcCtD
Temsirolimus—Chest pain—Losartan—type 2 diabetes mellitus	0.000105	0.000553	CcSEcCtD
Temsirolimus—Arthralgia—Losartan—type 2 diabetes mellitus	0.000105	0.000553	CcSEcCtD
Temsirolimus—Myalgia—Losartan—type 2 diabetes mellitus	0.000105	0.000553	CcSEcCtD
Temsirolimus—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000105	0.000553	CcSEcCtD
Temsirolimus—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000105	0.000552	CcSEcCtD
Temsirolimus—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000105	0.000552	CcSEcCtD
Temsirolimus—Anxiety—Losartan—type 2 diabetes mellitus	0.000105	0.000551	CcSEcCtD
Temsirolimus—Rash—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000548	CcSEcCtD
Temsirolimus—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000548	CcSEcCtD
Temsirolimus—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000104	0.000547	CcSEcCtD
Temsirolimus—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000104	0.000545	CcSEcCtD
Temsirolimus—Headache—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000545	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000104	0.000544	CcSEcCtD
Temsirolimus—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000103	0.000544	CcSEcCtD
Temsirolimus—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000102	0.000537	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000102	0.000536	CcSEcCtD
Temsirolimus—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000101	0.000532	CcSEcCtD
Temsirolimus—Somnolence—Metformin—type 2 diabetes mellitus	0.000101	0.000531	CcSEcCtD
Temsirolimus—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000101	0.00053	CcSEcCtD
Temsirolimus—Oedema—Losartan—type 2 diabetes mellitus	0.000101	0.00053	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000101	0.00053	CcSEcCtD
Temsirolimus—Infection—Losartan—type 2 diabetes mellitus	0.0001	0.000527	CcSEcCtD
Temsirolimus—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.0001	0.000526	CcSEcCtD
Temsirolimus—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.9e-05	0.00052	CcSEcCtD
Temsirolimus—Thrombocytopenia—Losartan—type 2 diabetes mellitus	9.88e-05	0.000519	CcSEcCtD
Temsirolimus—Decreased appetite—Metformin—type 2 diabetes mellitus	9.88e-05	0.000519	CcSEcCtD
Temsirolimus—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.86e-05	0.000518	CcSEcCtD
Temsirolimus—Nausea—Bromocriptine—type 2 diabetes mellitus	9.83e-05	0.000516	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	9.81e-05	0.000515	CcSEcCtD
Temsirolimus—Fatigue—Metformin—type 2 diabetes mellitus	9.8e-05	0.000515	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.77e-05	0.000513	CcSEcCtD
Temsirolimus—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.75e-05	0.000512	CcSEcCtD
Temsirolimus—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.75e-05	0.000512	CcSEcCtD
Temsirolimus—Asthenia—Gliclazide—type 2 diabetes mellitus	9.74e-05	0.000512	CcSEcCtD
Temsirolimus—Constipation—Metformin—type 2 diabetes mellitus	9.72e-05	0.00051	CcSEcCtD
Temsirolimus—Angioedema—Ramipril—type 2 diabetes mellitus	9.69e-05	0.000509	CcSEcCtD
Temsirolimus—Anorexia—Losartan—type 2 diabetes mellitus	9.62e-05	0.000505	CcSEcCtD
Temsirolimus—Vomiting—Glyburide—type 2 diabetes mellitus	9.62e-05	0.000505	CcSEcCtD
Temsirolimus—Pruritus—Gliclazide—type 2 diabetes mellitus	9.61e-05	0.000505	CcSEcCtD
Temsirolimus—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.56e-05	0.000502	CcSEcCtD
Temsirolimus—Rash—Glyburide—type 2 diabetes mellitus	9.54e-05	0.000501	CcSEcCtD
Temsirolimus—Somnolence—Irbesartan—type 2 diabetes mellitus	9.53e-05	0.000501	CcSEcCtD
Temsirolimus—Dermatitis—Glyburide—type 2 diabetes mellitus	9.53e-05	0.000501	CcSEcCtD
Temsirolimus—Leukopenia—Ramipril—type 2 diabetes mellitus	9.49e-05	0.000499	CcSEcCtD
Temsirolimus—Headache—Glyburide—type 2 diabetes mellitus	9.48e-05	0.000498	CcSEcCtD
Temsirolimus—Decreased appetite—Irbesartan—type 2 diabetes mellitus	9.32e-05	0.00049	CcSEcCtD
Temsirolimus—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.29e-05	0.000488	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.29e-05	0.000488	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.26e-05	0.000486	CcSEcCtD
Temsirolimus—Cough—Ramipril—type 2 diabetes mellitus	9.25e-05	0.000486	CcSEcCtD
Temsirolimus—Fatigue—Irbesartan—type 2 diabetes mellitus	9.25e-05	0.000486	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.19e-05	0.000483	CcSEcCtD
Temsirolimus—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.19e-05	0.000483	CcSEcCtD
Temsirolimus—Convulsion—Ramipril—type 2 diabetes mellitus	9.19e-05	0.000483	CcSEcCtD
Temsirolimus—Constipation—Irbesartan—type 2 diabetes mellitus	9.17e-05	0.000482	CcSEcCtD
Temsirolimus—Pain—Irbesartan—type 2 diabetes mellitus	9.17e-05	0.000482	CcSEcCtD
Temsirolimus—Insomnia—Losartan—type 2 diabetes mellitus	9.13e-05	0.00048	CcSEcCtD
Temsirolimus—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.08e-05	0.000477	CcSEcCtD
Temsirolimus—Arthralgia—Ramipril—type 2 diabetes mellitus	9.03e-05	0.000474	CcSEcCtD
Temsirolimus—Myalgia—Ramipril—type 2 diabetes mellitus	9.03e-05	0.000474	CcSEcCtD
Temsirolimus—Chest pain—Ramipril—type 2 diabetes mellitus	9.03e-05	0.000474	CcSEcCtD
Temsirolimus—Dyspnoea—Losartan—type 2 diabetes mellitus	9e-05	0.000473	CcSEcCtD
Temsirolimus—Anxiety—Ramipril—type 2 diabetes mellitus	9e-05	0.000473	CcSEcCtD
Temsirolimus—Nausea—Glyburide—type 2 diabetes mellitus	8.98e-05	0.000472	CcSEcCtD
Temsirolimus—Abdominal pain—Metformin—type 2 diabetes mellitus	8.98e-05	0.000472	CcSEcCtD
Temsirolimus—Dizziness—Gliclazide—type 2 diabetes mellitus	8.98e-05	0.000472	CcSEcCtD
Temsirolimus—Somnolence—Losartan—type 2 diabetes mellitus	8.97e-05	0.000471	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	8.96e-05	0.000471	CcSEcCtD
Temsirolimus—Asthenia—Valsartan—type 2 diabetes mellitus	8.95e-05	0.00047	CcSEcCtD
Temsirolimus—Asthenia—Orlistat—type 2 diabetes mellitus	8.85e-05	0.000465	CcSEcCtD
Temsirolimus—Pruritus—Valsartan—type 2 diabetes mellitus	8.83e-05	0.000464	CcSEcCtD
Temsirolimus—Decreased appetite—Losartan—type 2 diabetes mellitus	8.77e-05	0.000461	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.77e-05	0.000461	CcSEcCtD
Temsirolimus—Pruritus—Orlistat—type 2 diabetes mellitus	8.72e-05	0.000458	CcSEcCtD
Temsirolimus—Fatigue—Losartan—type 2 diabetes mellitus	8.7e-05	0.000457	CcSEcCtD
Temsirolimus—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.65e-05	0.000455	CcSEcCtD
Temsirolimus—Oedema—Ramipril—type 2 diabetes mellitus	8.65e-05	0.000455	CcSEcCtD
Temsirolimus—Vomiting—Gliclazide—type 2 diabetes mellitus	8.64e-05	0.000454	CcSEcCtD
Temsirolimus—Pain—Losartan—type 2 diabetes mellitus	8.63e-05	0.000453	CcSEcCtD
Temsirolimus—Constipation—Losartan—type 2 diabetes mellitus	8.63e-05	0.000453	CcSEcCtD
Temsirolimus—Rash—Gliclazide—type 2 diabetes mellitus	8.56e-05	0.00045	CcSEcCtD
Temsirolimus—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.56e-05	0.000449	CcSEcCtD
Temsirolimus—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.54e-05	0.000449	CcSEcCtD
Temsirolimus—Headache—Gliclazide—type 2 diabetes mellitus	8.51e-05	0.000447	CcSEcCtD
Temsirolimus—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.49e-05	0.000446	CcSEcCtD
Temsirolimus—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.48e-05	0.000445	CcSEcCtD
Temsirolimus—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.48e-05	0.000445	CcSEcCtD
Temsirolimus—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.47e-05	0.000445	CcSEcCtD
Temsirolimus—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.44e-05	0.000443	CcSEcCtD
Temsirolimus—Skin disorder—Ramipril—type 2 diabetes mellitus	8.41e-05	0.000442	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.25e-05	0.000434	CcSEcCtD
Temsirolimus—Dizziness—Valsartan—type 2 diabetes mellitus	8.25e-05	0.000433	CcSEcCtD
Temsirolimus—Anorexia—Ramipril—type 2 diabetes mellitus	8.25e-05	0.000433	CcSEcCtD
Temsirolimus—Dizziness—Orlistat—type 2 diabetes mellitus	8.15e-05	0.000428	CcSEcCtD
Temsirolimus—Asthenia—Metformin—type 2 diabetes mellitus	8.15e-05	0.000428	CcSEcCtD
Temsirolimus—Nausea—Gliclazide—type 2 diabetes mellitus	8.07e-05	0.000424	CcSEcCtD
Temsirolimus—Pruritus—Metformin—type 2 diabetes mellitus	8.04e-05	0.000422	CcSEcCtD
Temsirolimus—Abdominal pain—Losartan—type 2 diabetes mellitus	7.98e-05	0.000419	CcSEcCtD
Temsirolimus—Body temperature increased—Losartan—type 2 diabetes mellitus	7.98e-05	0.000419	CcSEcCtD
Temsirolimus—Vomiting—Valsartan—type 2 diabetes mellitus	7.93e-05	0.000417	CcSEcCtD
Temsirolimus—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.9e-05	0.000415	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.88e-05	0.000414	CcSEcCtD
Temsirolimus—Rash—Valsartan—type 2 diabetes mellitus	7.87e-05	0.000413	CcSEcCtD
Temsirolimus—Dermatitis—Valsartan—type 2 diabetes mellitus	7.86e-05	0.000413	CcSEcCtD
Temsirolimus—Vomiting—Orlistat—type 2 diabetes mellitus	7.84e-05	0.000412	CcSEcCtD
Temsirolimus—Insomnia—Ramipril—type 2 diabetes mellitus	7.83e-05	0.000411	CcSEcCtD
Temsirolimus—Headache—Valsartan—type 2 diabetes mellitus	7.82e-05	0.000411	CcSEcCtD
Temsirolimus—Diarrhoea—Metformin—type 2 diabetes mellitus	7.78e-05	0.000408	CcSEcCtD
Temsirolimus—Rash—Orlistat—type 2 diabetes mellitus	7.77e-05	0.000408	CcSEcCtD
Temsirolimus—Dermatitis—Orlistat—type 2 diabetes mellitus	7.77e-05	0.000408	CcSEcCtD
Temsirolimus—Headache—Orlistat—type 2 diabetes mellitus	7.72e-05	0.000406	CcSEcCtD
Temsirolimus—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.72e-05	0.000405	CcSEcCtD
Temsirolimus—Asthenia—Irbesartan—type 2 diabetes mellitus	7.69e-05	0.000404	CcSEcCtD
Temsirolimus—Somnolence—Ramipril—type 2 diabetes mellitus	7.69e-05	0.000404	CcSEcCtD
Temsirolimus—Pruritus—Irbesartan—type 2 diabetes mellitus	7.59e-05	0.000399	CcSEcCtD
Temsirolimus—Decreased appetite—Ramipril—type 2 diabetes mellitus	7.52e-05	0.000395	CcSEcCtD
Temsirolimus—Dizziness—Metformin—type 2 diabetes mellitus	7.51e-05	0.000395	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000392	CcSEcCtD
Temsirolimus—Fatigue—Ramipril—type 2 diabetes mellitus	7.46e-05	0.000392	CcSEcCtD
Temsirolimus—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.44e-05	0.000391	CcSEcCtD
Temsirolimus—Nausea—Valsartan—type 2 diabetes mellitus	7.41e-05	0.000389	CcSEcCtD
Temsirolimus—Constipation—Ramipril—type 2 diabetes mellitus	7.4e-05	0.000389	CcSEcCtD
Temsirolimus—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.34e-05	0.000385	CcSEcCtD
Temsirolimus—Nausea—Orlistat—type 2 diabetes mellitus	7.32e-05	0.000385	CcSEcCtD
Temsirolimus—Asthenia—Losartan—type 2 diabetes mellitus	7.24e-05	0.00038	CcSEcCtD
Temsirolimus—Vomiting—Metformin—type 2 diabetes mellitus	7.23e-05	0.00038	CcSEcCtD
Temsirolimus—Rash—Metformin—type 2 diabetes mellitus	7.16e-05	0.000376	CcSEcCtD
Temsirolimus—Dermatitis—Metformin—type 2 diabetes mellitus	7.16e-05	0.000376	CcSEcCtD
Temsirolimus—Pruritus—Losartan—type 2 diabetes mellitus	7.14e-05	0.000375	CcSEcCtD
Temsirolimus—Headache—Metformin—type 2 diabetes mellitus	7.12e-05	0.000374	CcSEcCtD
Temsirolimus—Dizziness—Irbesartan—type 2 diabetes mellitus	7.09e-05	0.000373	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.08e-05	0.000372	CcSEcCtD
Temsirolimus—Diarrhoea—Losartan—type 2 diabetes mellitus	6.91e-05	0.000363	CcSEcCtD
Temsirolimus—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000359	CcSEcCtD
Temsirolimus—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000359	CcSEcCtD
Temsirolimus—Vomiting—Irbesartan—type 2 diabetes mellitus	6.82e-05	0.000358	CcSEcCtD
Temsirolimus—Rash—Irbesartan—type 2 diabetes mellitus	6.76e-05	0.000355	CcSEcCtD
Temsirolimus—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.76e-05	0.000355	CcSEcCtD
Temsirolimus—Nausea—Metformin—type 2 diabetes mellitus	6.75e-05	0.000355	CcSEcCtD
Temsirolimus—Headache—Irbesartan—type 2 diabetes mellitus	6.72e-05	0.000353	CcSEcCtD
Temsirolimus—Dizziness—Losartan—type 2 diabetes mellitus	6.67e-05	0.000351	CcSEcCtD
Temsirolimus—Vomiting—Losartan—type 2 diabetes mellitus	6.42e-05	0.000337	CcSEcCtD
Temsirolimus—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000335	CcSEcCtD
Temsirolimus—Nausea—Irbesartan—type 2 diabetes mellitus	6.37e-05	0.000335	CcSEcCtD
Temsirolimus—Rash—Losartan—type 2 diabetes mellitus	6.36e-05	0.000334	CcSEcCtD
Temsirolimus—Dermatitis—Losartan—type 2 diabetes mellitus	6.36e-05	0.000334	CcSEcCtD
Temsirolimus—Headache—Losartan—type 2 diabetes mellitus	6.32e-05	0.000332	CcSEcCtD
Temsirolimus—Asthenia—Ramipril—type 2 diabetes mellitus	6.21e-05	0.000326	CcSEcCtD
Temsirolimus—Pruritus—Ramipril—type 2 diabetes mellitus	6.12e-05	0.000322	CcSEcCtD
Temsirolimus—Nausea—Losartan—type 2 diabetes mellitus	5.99e-05	0.000315	CcSEcCtD
Temsirolimus—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000311	CcSEcCtD
Temsirolimus—Dizziness—Ramipril—type 2 diabetes mellitus	5.72e-05	0.000301	CcSEcCtD
Temsirolimus—Vomiting—Ramipril—type 2 diabetes mellitus	5.5e-05	0.000289	CcSEcCtD
Temsirolimus—Rash—Ramipril—type 2 diabetes mellitus	5.46e-05	0.000287	CcSEcCtD
Temsirolimus—Dermatitis—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000286	CcSEcCtD
Temsirolimus—Headache—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000285	CcSEcCtD
Temsirolimus—Nausea—Ramipril—type 2 diabetes mellitus	5.14e-05	0.00027	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.63e-06	6.71e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	7.6e-06	6.68e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.55e-06	6.64e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPP2CA—type 2 diabetes mellitus	7.54e-06	6.63e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	7.53e-06	6.62e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	7.53e-06	6.62e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	7.41e-06	6.51e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	7.41e-06	6.51e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	7.37e-06	6.48e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	7.37e-06	6.48e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.35e-06	6.46e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.35e-06	6.46e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.35e-06	6.46e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.31e-06	6.43e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.3e-06	6.41e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AGT—type 2 diabetes mellitus	7.29e-06	6.41e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	7.24e-06	6.36e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	7.23e-06	6.36e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	7.19e-06	6.32e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	7.19e-06	6.32e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	7.19e-06	6.32e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.16e-06	6.3e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	7.14e-06	6.28e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOE—type 2 diabetes mellitus	7.14e-06	6.28e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—LEP—type 2 diabetes mellitus	7.14e-06	6.28e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	7.1e-06	6.24e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	7.09e-06	6.24e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—type 2 diabetes mellitus	7.08e-06	6.22e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.06e-06	6.2e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.05e-06	6.2e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.05e-06	6.2e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.03e-06	6.18e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	7.01e-06	6.17e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—type 2 diabetes mellitus	6.99e-06	6.14e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	6.95e-06	6.11e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	6.95e-06	6.11e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	6.93e-06	6.09e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	6.88e-06	6.05e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.85e-06	6.02e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	6.81e-06	5.99e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	6.81e-06	5.98e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.79e-06	5.97e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.79e-06	5.97e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	6.77e-06	5.95e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	6.77e-06	5.95e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	6.77e-06	5.95e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—type 2 diabetes mellitus	6.77e-06	5.95e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	6.76e-06	5.94e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	6.74e-06	5.92e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.73e-06	5.92e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	6.73e-06	5.92e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.67e-06	5.86e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	6.66e-06	5.86e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	6.61e-06	5.81e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NFKB1—type 2 diabetes mellitus	6.57e-06	5.77e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.55e-06	5.76e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.55e-06	5.76e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.55e-06	5.76e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	6.53e-06	5.74e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—AKT1—type 2 diabetes mellitus	6.53e-06	5.74e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	6.45e-06	5.67e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	6.45e-06	5.67e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	6.45e-06	5.67e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	6.38e-06	5.61e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.38e-06	5.61e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.37e-06	5.6e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	6.35e-06	5.59e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	6.33e-06	5.56e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.29e-06	5.53e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	6.27e-06	5.51e-05	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—AKT1—type 2 diabetes mellitus	6.27e-06	5.51e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	6.27e-06	5.51e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—AKT1—type 2 diabetes mellitus	6.24e-06	5.49e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.17e-06	5.42e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.16e-06	5.42e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.15e-06	5.4e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	6.14e-06	5.39e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—SRC—type 2 diabetes mellitus	6.12e-06	5.38e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—INS—type 2 diabetes mellitus	6.1e-06	5.36e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	6.09e-06	5.35e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	6.07e-06	5.34e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	6.07e-06	5.34e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	6.07e-06	5.34e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL2—type 2 diabetes mellitus	6e-06	5.28e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	5.96e-06	5.24e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	5.92e-06	5.2e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	5.91e-06	5.19e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.9e-06	5.19e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.89e-06	5.18e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	5.89e-06	5.18e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	5.87e-06	5.16e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.83e-06	5.12e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.83e-06	5.12e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	5.81e-06	5.11e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	5.78e-06	5.08e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.77e-06	5.07e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	5.76e-06	5.06e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	5.69e-06	5e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.68e-06	5e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	5.67e-06	4.98e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SRC—type 2 diabetes mellitus	5.65e-06	4.97e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.6e-06	4.92e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	5.59e-06	4.91e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.59e-06	4.91e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.57e-06	4.9e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.57e-06	4.9e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.57e-06	4.9e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.57e-06	4.9e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	5.55e-06	4.88e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	5.52e-06	4.85e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	5.49e-06	4.83e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	5.49e-06	4.83e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	5.45e-06	4.79e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EGFR—type 2 diabetes mellitus	5.36e-06	4.72e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	5.36e-06	4.71e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.35e-06	4.7e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.35e-06	4.7e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.34e-06	4.7e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	5.28e-06	4.64e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	5.27e-06	4.63e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	5.27e-06	4.63e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	5.23e-06	4.6e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	5.13e-06	4.51e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—type 2 diabetes mellitus	5.05e-06	4.44e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	5.05e-06	4.44e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	5.05e-06	4.44e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RELA—type 2 diabetes mellitus	5.03e-06	4.43e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	4.97e-06	4.37e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.97e-06	4.37e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EGFR—type 2 diabetes mellitus	4.95e-06	4.35e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	4.89e-06	4.3e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	4.87e-06	4.28e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.82e-06	4.23e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.82e-06	4.23e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	4.82e-06	4.23e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.79e-06	4.21e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.74e-06	4.17e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4.73e-06	4.16e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.64e-06	4.08e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	4.62e-06	4.06e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	4.59e-06	4.04e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.54e-06	3.99e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.54e-06	3.99e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.54e-06	3.99e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	4.54e-06	3.99e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.54e-06	3.99e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	4.52e-06	3.97e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	4.47e-06	3.93e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	4.46e-06	3.92e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.46e-06	3.92e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.43e-06	3.89e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.43e-06	3.89e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.43e-06	3.89e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.4e-06	3.87e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	4.38e-06	3.85e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.37e-06	3.84e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	4.33e-06	3.8e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.32e-06	3.8e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	4.29e-06	3.77e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.29e-06	3.77e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	4.28e-06	3.76e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.27e-06	3.75e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.25e-06	3.73e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	4.24e-06	3.73e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.21e-06	3.7e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	4.17e-06	3.66e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	4.16e-06	3.66e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.13e-06	3.63e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—type 2 diabetes mellitus	4.12e-06	3.62e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.11e-06	3.62e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	4.05e-06	3.56e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	4.03e-06	3.54e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.97e-06	3.49e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.97e-06	3.49e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.97e-06	3.49e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SRC—type 2 diabetes mellitus	3.96e-06	3.48e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.95e-06	3.47e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.93e-06	3.45e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.9e-06	3.43e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.88e-06	3.41e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.87e-06	3.41e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.86e-06	3.4e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.85e-06	3.39e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.81e-06	3.35e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—type 2 diabetes mellitus	3.81e-06	3.35e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—AKT1—type 2 diabetes mellitus	3.8e-06	3.34e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.78e-06	3.32e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.75e-06	3.3e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.72e-06	3.27e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.69e-06	3.24e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.68e-06	3.23e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.65e-06	3.21e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.65e-06	3.21e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.65e-06	3.21e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.63e-06	3.19e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.63e-06	3.19e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.59e-06	3.16e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.59e-06	3.16e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.54e-06	3.11e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.54e-06	3.11e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—AKT1—type 2 diabetes mellitus	3.51e-06	3.09e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.48e-06	3.06e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.47e-06	3.05e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.46e-06	3.05e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.44e-06	3.03e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.44e-06	3.03e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	3.42e-06	3.01e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	3.34e-06	2.93e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.2e-06	2.81e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.14e-06	2.76e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.02e-06	2.65e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.97e-06	2.61e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.97e-06	2.61e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.96e-06	2.6e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.95e-06	2.6e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.91e-06	2.56e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.88e-06	2.53e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.83e-06	2.49e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.75e-06	2.42e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.75e-06	2.42e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.75e-06	2.42e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.71e-06	2.38e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.7e-06	2.38e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—type 2 diabetes mellitus	2.66e-06	2.34e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.64e-06	2.33e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.64e-06	2.32e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.59e-06	2.28e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.59e-06	2.28e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.57e-06	2.26e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.53e-06	2.23e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.52e-06	2.21e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.46e-06	2.16e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.43e-06	2.14e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.39e-06	2.1e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.37e-06	2.09e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	2.32e-06	2.04e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.31e-06	2.03e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.27e-06	2e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.26e-06	1.99e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.24e-06	1.97e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.97e-06	1.73e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.93e-06	1.7e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.77e-06	1.56e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.7e-06	1.49e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.7e-06	1.49e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.68e-06	1.47e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.55e-06	1.36e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.27e-06	1.11e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.19e-06	1.05e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.8e-07	6.86e-06	CbGpPWpGaD
